Vimarsana
Biggest News Aggregation in the World

Page 3 - Eric Schoen News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Eric Schoen. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Eric Schoen Today - Breaking & Trending Today

Cassava Sciences Completes Enrollment for Pivotal Phase 3 Program of Simufilam in Alzheimer's Disease -November 06, 2023 at 09:16 am EST - Vimarsana News

Cassava Sciences Completes Enrollment for Pivotal Phase 3 Program of Simufilam in Alzheimer's Disease -November 06, 2023 at 09:16 am EST

1,929 patients randomized in a pair of Phase 3 trials to evaluate oral simufilam in Alzheimer's disease dementia.Top-line results for on-going, 52-week Phase 3 trial expected approximately year-end...

MRI Data Suggest Simufilam is Not Associated with - Vimarsana News

MRI Data Suggest Simufilam is Not Associated with

Safety Finding Based on Blinded MRI Brain Data at Week 40ARIA is a Known Risk Factor for Anti-Amyloid Antibody DrugsMRI Data Presented at the 16th CTAD...

Statement by Cassava Sciences Regarding an Internal CUNY Report Leaked to the Press - Vimarsana News

Statement by Cassava Sciences Regarding an Internal CUNY Report Leaked to the Press

CUNY’s report makes no findings of data manipulation.The “egregious misconduct” cited in the report relates to internal record-keeping failures at CUNY.CUNY’s report finds that internal...

Statement by Cassava Sciences Regarding an Internal CUNY - Vimarsana News

Statement by Cassava Sciences Regarding an Internal CUNY

CUNY’s report makes no findings of data manipulation.The “egregious misconduct” cited in the report relates to internal record-keeping failures at...

Why Shares of Cassava Sciences Soared This Week - Vimarsana News

Why Shares of Cassava Sciences Soared This Week

Cassava bounced back from hitting a 52-week low to start the week.

Source: fool.com